Home›Questions on Notice›QoN 176

❓ Question on Notice regarding Janssen-Cilag drug trials at Fremantle Hospital, including approval processes, funding, patient information, adverse events, and referral sources. The answer confirms multiple trials and refers to a tabled paper for details.

AnsweredQoN 176Legislative Council

Asked

27 June 2013

Member

Hon Sally Talbot

Portfolio

Health

QuestionView source ↗

(1) Did Janssen-Cilag Pty Ltd run a drug trial at Fremantle Hospital? (2) If so, when and who approved it? (3) What drug was the drug trial for? (4) Did Janssen-Cilag Pty Ltd make payments to Fremantle Hospital for information? (5) If so, how much was the payment and for what information was the hospital paid? (6) How much funding was paid to Fremantle Hospital for each patient on the trial? (7) How was the funding disbursed and to whom? (8) Who made this disbursement decision? (9) How many of the participants in this trial were involuntary patients? (10) What were these patients told about the trial? (11) If so, what records were made? (12) Where are the records? (13) Were there any Serious Adverse Events arising in any patients at the time they were on the trial or any time after the drugs were stopped that could be related to the drugs the subject of the trial? (14) Who were all the internal and external referral sources for the trial (please provide details of companies/individuals)?